[
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often preven",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "NCE MIAME LC DIA PRIDE:0000834 biosample accession number developmental stage WILL II MAY sample exclamation NCI URI WARRANTY THAT ancestry category VCF MS:1001251 MOD VK IMPLIED MUST BE PRIDE:0000833 STANDARDS CLO XL NT EW DISCLAIMS MT ZFA BMC README PTM label CS REQUIRED RECOMMEND PURPOSE cell type IS collision energy FDR PO RECOMMENDED INCLUDING CT OPTIONAL IAA IMPORTANT JA depletion INFRINGE HTML COULD SAMEA CPTAC dissociation method SILAC HCD ENVO WARRANTIES CELL sex AC SH individual MHC TMT fractionation method TO MERCHANTABILITY SRM mass THE CF HUPO IDF CN III organism part OR TIP cleavage agent details ID RFC reduction reagent NCIT:C25714 BRENDA MAJOR alkylation reagent INFORMATION HF MC age PATCH ISA PP PEPTIDESEQ SHALL technical replicate data file NCBI ANY PRM instrument INITIATIVE MONDO BUT USE PRIDE disease EFO SP PRIDE:0000831 LIMITED proteomics data acquisition method PATO PROTEOMICS NCIT:C25683 biological replicate NOT characteristics fraction identifier RAW SDRF NCIT BTO SN EXPRESS CL HANCESTRO TA pooled sample ALL UBERON organism NOTE CV DTT HEREIN FOR MINOR RIGHTS PARTICULAR spiked compound ROW TAB CID ... COLUMN URL PMID MS EBI DJ SWATH LI QY XML PSI SAMN SHOULD EM PMCID file your AS source name PRIDE:0000832 REQUIRES PS PRIDE:0000659 FITNESS MAGE OF DDA"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often preven",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "NCE MIAME LC DIA PRIDE:0000834 biosample accession number WILL II MAY NCI URI WARRANTY THAT VCF MS:1001251 MOD VK IMPLIED MUST BE PRIDE:0000833 STANDARDS CLO XL NT EW DISCLAIMS MT ZFA BMC README PTM label CS REQUIRED RECOMMEND PURPOSE cell type IS collision energy FDR PO RECOMMENDED INCLUDING CT OPTIONAL IAA JA depletion INFRINGE HTML COULD SAMEA CPTAC dissociation method SILAC HCD ENVO WARRANTIES CELL AC SH individual MHC TMT fractionation method TO MERCHANTABILITY SRM mass THE CF HUPO IDF CN III organism part OR cleavage agent details RFC reduction reagent NCIT:C25714 BRENDA MAJOR alkylation reagent INFORMATION HF MC age PATCH ISA PP PEPTIDESEQ SHALL technical replicate data file NCBI ANY PRM instrument INITIATIVE MONDO BUT USE PRIDE disease EFO SP PRIDE:0000831 LIMITED proteomics data acquisition method PATO PROTEOMICS NCIT:C25683 biological replicate NOT fraction identifier RAW SDRF NCIT BTO SN EXPRESS CL HANCESTRO TA pooled sample ALL UBERON organism CV DTT HEREIN FOR MINOR RIGHTS PARTICULAR spiked compound ROW TAB CID ... COLUMN URL PMID MS EBI DJ SWATH LI QY PSI SAMN SHOULD EM PMCID AS PRIDE:0000832 REQUIRES PS PRIDE:0000659 FITNESS MAGE OF DDA"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nliver |UBERON:0002107 |Liver tissue\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hours post fertilization).\n\nDisease\n\nColumn: characteristics[disease]\n\nOntology: MONDO Disease Ontology (preferred), EFO, Human Disease Ontology (DOID)\n\nFor healthy controls, use normal (mapped to PATO:0000461). For animal disease models, use the human disease name (e.g., Alzheimer disease for APP/PS1 mice).\n\nDise",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "organism age CL:0000624 xenograft depletion developmental stage NCBI PO MAY exclamation synthetic peptide MONDO UBERON:0000178 disease UBERON:0002107 EFO CL:0000815 APP MUST enrichment process MONDO:0004989 PATO CL:0000084 PATO:0000461 SDRF PTM PDX ID CL DOID cell type organism part CL:0000066 UBERON"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nliver |UBERON:0002107 |Liver tissue\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hours post fertilization).\n\nDisease\n\nColumn: characteristics[disease]\n\nOntology: MONDO Disease Ontology (preferred), EFO, Human Disease Ontology (DOID)\n\nFor healthy controls, use normal (mapped to PATO:0000461). For animal disease models, use the human disease name (e.g., Alzheimer disease for APP/PS1 mice).\n\nDise",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "organism age CL:0000624 xenograft depletion developmental stage NCBI PO MAY synthetic peptide MONDO UBERON:0000178 disease UBERON:0002107 EFO CL:0000815 APP MUST enrichment process MONDO:0004989 PATO CL:0000084 PATO:0000461 SDRF PTM PDX ID CL DOID cell type organism part CL:0000066 UBERON"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C27966 IMPORTANT weight disease stage HANCESTRO:0005 NCIT:C71732 NCIT:C28078 CHEBI:27899 exclamation pre-existing condition NCIT:C4870 TNM NCI NCIT:C65106 breast cancer subtype NCIT:C27971 treatment status smoking status MONDO HANCESTRO:0009 HIPAA ancestry category treatment treatment response sampling time point individual NCIT:C53554 NCIT:C18206 NCIT:C65108 MONDO:0005044 body mass index IV NCIT:C15632 PR SDRF NCIT:C15262 dose organism part NCIT TNM staging NCIT:C28076 GDPR NCIT:C65107 Dukes stage Ann Arbor stage menopausal status ID MONDO:0005148 tumor grade CHEBI:28748 HANCESTRO ER AJCC compound"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C27966 weight disease stage HANCESTRO:0005 NCIT:C71732 NCIT:C28078 CHEBI:27899 pre-existing condition NCIT:C4870 TNM NCI NCIT:C65106 breast cancer subtype NCIT:C27971 treatment status smoking status MONDO HANCESTRO:0009 HIPAA ancestry category treatment treatment response sampling time point individual NCIT:C53554 NCIT:C18206 NCIT:C65108 MONDO:0005044 body mass index IV NCIT:C15632 PR SDRF NCIT:C15262 dose organism part NCIT TNM staging NCIT:C28076 GDPR NCIT:C65107 Dukes stage Ann Arbor stage menopausal status ID MONDO:0005148 tumor grade CHEBI:28748 HANCESTRO ER AJCC compound"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides detailed guidelines for data file metadata fields that require specific formatting or have complex standardization requirements. For basic field descriptions, see the main SDRF-Proteomics specification.\n\nVersion 1.0.0 - 2025-01\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119, iTRAQ121\n\nSILAC labels: SILAC light, SILAC medium, SILAC heavy\n\nMS2 Analyzer Type\n\nColumn: comment[MS2 analyzer type]\n\nSpecifies the analyzer used for MS2 scans. Important for hybrid instruments.\n\nValues: orbitrap, ion trap, quadrupole.\n\nDIA Scan Window\n\nColumn: comment[MS1 scan range]\n\nFormat: {lower}m/z - {upper}m/z (e.g., 400m/z - 1200m/z)\n\nAlternative: Use comment[scan window lower limit] and comment[scan window upper limit] as separate columns.\n\nProtein Modifications\n\nColumn: comment[modification parameters]\n\nFormat: Key=value pairs: NT=ModificationName;AC=Accession;MT=Type;TA=AminoAcid;PP=Position\n\nProperty |Key |Description\n\nName |NT |Modification name (UNIMOD or PSI-MOD)\nAccession |AC |UNIMOD or PSI-MOD accession\n\nCommon modifications:\n\nModification |Value\n\nCarbamidomethyl (fixed) |NT=Carbamidomethyl;AC=UNIMOD:4;MT=Fixed;TA=C\nOxidation (variable) |NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M\n\nCleavage Agents\n\nColumn: comment[cleavage agent details]\n\nREQUIRED.\n\nFormat: NT=EnzymeName;AC=Accession\n\nEnzyme |Value\n\nTrypsin |NT=Trypsin;AC=MS:1001251\nLys-C |NT=Lys-C;AC=MS:1001309\n\nFor top-down/intact proteins, use not applicable. For multiple enzymes, add multiple columns.\n\nMass Tolerances\n\nColumns: comment[precursor mass tolerance], comment[fragment mass tolerance]\n\nForm",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "DIA PP MS:1001309 fragment mass tolerance modification parameters SILAC exclamation AC PRIDE MS MS:1001251 MOD TMT UNIMOD UNIMOD:35 NT precursor mass tolerance PSI SDRF MT scan window lower limit MS1 scan range README scan window upper limit label cleavage agent details UNIMOD:4 REQUIRED MS2 analyzer type TA"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides detailed guidelines for data file metadata fields that require specific formatting or have complex standardization requirements. For basic field descriptions, see the main SDRF-Proteomics specification.\n\nVersion 1.0.0 - 2025-01\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119, iTRAQ121\n\nSILAC labels: SILAC light, SILAC medium, SILAC heavy\n\nMS2 Analyzer Type\n\nColumn: comment[MS2 analyzer type]\n\nSpecifies the analyzer used for MS2 scans. Important for hybrid instruments.\n\nValues: orbitrap, ion trap, quadrupole.\n\nDIA Scan Window\n\nColumn: comment[MS1 scan range]\n\nFormat: {lower}m/z - {upper}m/z (e.g., 400m/z - 1200m/z)\n\nAlternative: Use comment[scan window lower limit] and comment[scan window upper limit] as separate columns.\n\nProtein Modifications\n\nColumn: comment[modification parameters]\n\nFormat: Key=value pairs: NT=ModificationName;AC=Accession;MT=Type;TA=AminoAcid;PP=Position\n\nProperty |Key |Description\n\nName |NT |Modification name (UNIMOD or PSI-MOD)\nAccession |AC |UNIMOD or PSI-MOD accession\n\nCommon modifications:\n\nModification |Value\n\nCarbamidomethyl (fixed) |NT=Carbamidomethyl;AC=UNIMOD:4;MT=Fixed;TA=C\nOxidation (variable) |NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M\n\nCleavage Agents\n\nColumn: comment[cleavage agent details]\n\nREQUIRED.\n\nFormat: NT=EnzymeName;AC=Accession\n\nEnzyme |Value\n\nTrypsin |NT=Trypsin;AC=MS:1001251\nLys-C |NT=Lys-C;AC=MS:1001309\n\nFor top-down/intact proteins, use not applicable. For multiple enzymes, add multiple columns.\n\nMass Tolerances\n\nColumns: comment[precursor mass tolerance], comment[fragment mass tolerance]\n\nForm",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "DIA PP MS:1001309 fragment mass tolerance modification parameters SILAC AC MS PRIDE MS:1001251 MOD TMT UNIMOD UNIMOD:35 NT precursor mass tolerance PSI SDRF MT scan window lower limit MS1 scan range scan window upper limit label cleavage agent details UNIMOD:4 REQUIRED MS2 analyzer type TA"
  }
]